Efficacy and Safety of Hypomethylating Agents in Chronic Myelomonocytic Leukemia: A Single-Arm Meta-analysis

Background  Chronic myelomonocytic leukemia (CMML) is a myeloid neoplasm with features of the myelodysplastic syndromes (MDSs) and myeloproliferative neoplasm presenting with peripheral blood monocytosis and an inherent risk for transformation to acute myeloid leukemia, while the abnormal DNA methyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xinhui, Lv, Liwei, Li, Xiangjun, Jiang, Erlie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192189/
https://www.ncbi.nlm.nih.gov/pubmed/35707788
http://dx.doi.org/10.1055/s-0042-1744157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192189/
https://www.ncbi.nlm.nih.gov/pubmed/35707788
http://dx.doi.org/10.1055/s-0042-1744157

Ejemplares similares